PRODUCTION, PURIFICATION AND CHARACTERIZATION OF A RABBIT RECOMBINANT IL-1 RECEPTOR ANTAGONIST

被引:21
作者
MATSUKAWA, A [1 ]
MORI, S [1 ]
OHKAWARA, S [1 ]
MAEDA, T [1 ]
TANASE, S [1 ]
EDAMITSU, S [1 ]
YANAGI, F [1 ]
YOSHINAGA, M [1 ]
机构
[1] KUMAMOTO UNIV, SCH MED, DEPT BIOCHEM, KUMAMOTO 860, JAPAN
来源
BIOMEDICAL RESEARCH-TOKYO | 1992年 / 13卷 / 04期
关键词
D O I
10.2220/biomedres.13.269
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
We describe here the mature translation product of the cDNA for rabbit IL-1 receptor antagonist (IL-1ra) expressed in E.coli. The rabbit recombinant IL-1ra (rrIL-1ra) was purified using DEAE-cellulose and Sephadex G-75, in a conventional chromatography system, followed by a linear NaCl gradient-elution of DEAE-cellulose in an FPLC system. The purified rrIL-1ra was composed of 143 amino acid residues. It had a molecular mass of 19 kD on SDS-PAGE and an isoelectric point of 5.85 on IEF-PAGE. Amino acid sequence analysis of rrIL-1ra showed that the native N-terminal Met was maintained. Specific biological activity of rrIL-1ra was 2.5 x 10(5) units/mg protein, a value indistinguishable from that of the native factor of rabbit inflammatory exudate cells when assessed by using thymocyte co-mitogenic assay. These observations suggest that rrIL-1ra emulates properties of the native protein. This rrIL-1ra manifested inhibition of rabbit rIL-1-beta- and human rIL-1-alpha- and rIL-1-beta-induced proliferation of mouse thymocytes and also inhibited IL-1 activities in culture supernatants of mononuclear cells from animals, including the rabbit, rat, mouse, guinea pig and from human. Thus, rrIL-1ra provides a useful tool for testing IL-1 activities exhibited by both IL-1-alpha and beta in a wide range of species of experimental animals.
引用
收藏
页码:269 / 277
页数:9
相关论文
共 25 条
[11]   INTERLEUKIN-1 RECEPTOR ANTAGONIST ACTIVITY OF A HUMAN INTERLEUKIN-1 INHIBITOR [J].
HANNUM, CH ;
WILCOX, CJ ;
AREND, WP ;
JOSLIN, FG ;
DRIPPS, DJ ;
HEIMDAL, PL ;
ARMES, LG ;
SOMMER, A ;
EISENBERG, SP ;
THOMPSON, RC .
NATURE, 1990, 343 (6256) :336-340
[12]  
HEWICK RM, 1981, J BIOL CHEM, V256, P7990
[13]   PURIFICATION AND CHARACTERIZATION OF RECOMBINANT HUMAN INTERLEUKIN-1-BETA PRODUCED IN ESCHERICHIA-COLI [J].
KIKUMOTO, Y ;
HONG, YM ;
NISHIDA, T ;
NAKAI, S ;
MASUI, Y ;
HIRAI, Y .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1987, 147 (01) :315-321
[14]   CLEAVAGE OF STRUCTURAL PROTEINS DURING ASSEMBLY OF HEAD OF BACTERIOPHAGE-T4 [J].
LAEMMLI, UK .
NATURE, 1970, 227 (5259) :680-+
[15]   NATIVE INTERLEUKIN-1 INHIBITORS [J].
LARRICK, JW .
IMMUNOLOGY TODAY, 1989, 10 (02) :61-66
[16]   IDENTIFICATION OF A SPECIFIC INTERLEUKIN-1 INHIBITOR IN THE URINE OF FEBRILE PATIENTS [J].
LIAO, Z ;
GRIMSHAW, RS ;
ROSENSTREICH, DL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1984, 159 (01) :126-136
[17]  
Maniatis T., 1982, MOL CLONING
[18]   INTERLEUKIN-1 RECEPTOR ANTAGONIST REDUCES MORTALITY FROM ENDOTOXIN-SHOCK [J].
OHLSSON, K ;
BJORK, P ;
BERGENFELDT, M ;
HAGEMAN, R ;
THOMPSON, RC .
NATURE, 1990, 348 (6301) :550-552
[19]   INTERLEUKIN-1-RECEPTOR ANTAGONIST BLOCKS INTERLEUKIN-1-INDUCED SLEEP AND FEVER [J].
OPP, MR ;
KRUEGER, JM .
AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 260 (02) :R453-R457
[20]   THERE IS MORE THAN ONE INTERLEUKIN-1 [J].
OPPENHEIM, JJ ;
KOVACS, EJ ;
MATSUSHIMA, K ;
DURUM, SK .
IMMUNOLOGY TODAY, 1986, 7 (02) :45-56